Annual report for Vineet Laboratories Ltd. for FY-2022
29-05-2022
Vineet Laboratories Ltd - 543298 - Corporate Action-Board approves Dividend
The Board of Directors in the meeting held on 28 May, 2022 has recommended Final Dividend at Re.1/- per equity share of Face Value of Rs.10 each for the financial year ended March 31, 2022.28-05-2022
Vineet Laboratories Ltd - 543298 - Board Meeting Outcome for Outcome Of Board Meeting Held On 28 May, 2022
The Board of Directors of the company in its meeting held today i.e., on May 28, 2022 has considered and approved the following: 1. The Annual Audited Financial Results of the company for the Fourth Quarter and the Financial Year ended on 31st March, 2022; 2. The Annual Audited Financial Statements for the financial year 2021-2022; 3. Independent Auditor's Report on Quarterly Standalone Financial Results and Year to Date. 4. Recommended Final Dividend at Re.1/- per equity share of Face Value of Rs.10 each for the financial year ended March 31, 2022. The Board Meeting commenced at 04.00 PM and concluded at 08.00 PM28-05-2022
Vineet Laboratories Ltd - 543298 - Corporate Action-Board to consider Dividend
In continuation to our intimation dated May 20, 2022 to the stock exchange(s), the Board of Directors in its meeting scheduled to be held on May 28, 2022, among other items of agenda, is going to consider the possibility of recommending the dividend for the financial year ended 31 March, 2022.25-05-2022
Vineet Laboratories Ltd - 543298 - Board Meeting Intimation for Intimation Of The Date Of Board Meeting Under Regulation 29 Of SEBI (Listing Obligations And Disclosure Requirements) Regulations, 2015.
Vineet Laboratories Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 28/05/2022 ,inter alia, to consider and approve This is to inform you that a meeting of Board of Directors of the Company is scheduled to be held on Saturday, May 28, 2022 at 4:00pm. The purpose of the Board Meeting is - among other matters- 1. The Annual Audited Financial Results for the Fourth Quarter and Financial Year ended 31st March 2022; 2. The Annual Audited Financial Statements for the financial year 2021-2022; 3. Other Corporate Matters.20-05-2022
Vineet Laboratories Ltd - 543298 - Appointment of Company Secretary and Compliance Officer
Ms. Nirosha Ravikanti, Associate member of the Institute of Company Secretaries of India, having Membership No: A68115, has been appointed as Company Secretary and Compliance Officer of the Company with effect from April 28th, 2022.28-04-2022
Vineet Laboratories Ltd - 543298 - Certificate Under Regulation 40(9) And 40 (10) Of The Securities Exchange Board Of India (Listing Obligations And Disclosure Requirements) Regulations, 2015.
Pursuant to Regulation 40 (9) and 40 (10) of the Securities Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015, we are hereby enclosing the certificate received from Practicing Company Secretary for the financial year ended on March 31, 2022.26-04-2022
Vineet Laboratories Ltd - 543298 - Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018
We are hereby submitting the certificate in compliance with Regulation 74(5) of the SEBI (Depositories and Participants) Regulations, 2018 for the quarter ended on 31-03-2022.09-04-2022
Vineet Laboratories Ltd - 543298 - Statement Of Investor Complaints For The Quarter Ended March 2022
No.of Investor complaints pending at the beginning of the quarter No.of Investor complaints received during the quarter No.of Investor complaints disposed of during the quarter No.of Investor complaints unresolved at the end of the quarter 0110 Name of the Signatory :- Gaddam Venkata RamanaDesignation :- Managing Director / Whole Time Director09-04-2022
Vineet Laboratories Ltd - 543298 - Clarification On Price Movement
Kindly note that we, the Company, have disclosed all the events, information that have a bearing on the operation / performance of the Company which include all price sensitive information to the stock exchanges and the investors as required under Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015. Further, we would like to bring to your kind attention that there is no pending information / announcement, whether price sensitive or not, which has to be brought to the knowledge of the stock exchanges and the investors. The movement in the share price of the company is purely market driven including the impact of systematic and unsystematic risks being faced by the company that are neither in the control of the company nor the management.09-04-2022